Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS
Clinical trial NCT02303769 · COMPLETED
Trial details
- NCT number
- NCT02303769
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.